CN102937650B - 一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 - Google Patents
一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 Download PDFInfo
- Publication number
- CN102937650B CN102937650B CN201210455868.1A CN201210455868A CN102937650B CN 102937650 B CN102937650 B CN 102937650B CN 201210455868 A CN201210455868 A CN 201210455868A CN 102937650 B CN102937650 B CN 102937650B
- Authority
- CN
- China
- Prior art keywords
- quality control
- antigen
- critical quality
- band
- film bar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001228 spectrum Methods 0.000 title claims abstract description 18
- 239000012528 membrane Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 208000027761 Hepatic autoimmune disease Diseases 0.000 title description 6
- 238000003908 quality control method Methods 0.000 claims abstract description 121
- 239000000427 antigen Substances 0.000 claims abstract description 100
- 102000036639 antigens Human genes 0.000 claims abstract description 100
- 108091007433 antigens Proteins 0.000 claims abstract description 100
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 16
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 16
- 102000007469 Actins Human genes 0.000 claims abstract description 15
- 108010085238 Actins Proteins 0.000 claims abstract description 15
- 239000004677 Nylon Substances 0.000 claims abstract description 10
- 229920001778 nylon Polymers 0.000 claims abstract description 10
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 33
- 208000019423 liver disease Diseases 0.000 claims description 24
- 230000005784 autoimmunity Effects 0.000 claims description 23
- 239000000758 substrate Substances 0.000 claims description 16
- 238000002474 experimental method Methods 0.000 claims description 13
- 239000011521 glass Substances 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 238000013016 damping Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 claims description 7
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims description 6
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims description 6
- 230000008719 thickening Effects 0.000 claims description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 5
- 239000007983 Tris buffer Substances 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 208000006454 hepatitis Diseases 0.000 claims description 4
- 231100000283 hepatitis Toxicity 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 206010002449 angioimmunoblastic T-cell lymphoma Diseases 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 32
- 238000012360 testing method Methods 0.000 description 25
- 210000002966 serum Anatomy 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 101710171243 Peroxidase 10 Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000010185 immunofluorescence analysis Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210455868.1A CN102937650B (zh) | 2012-11-14 | 2012-11-14 | 一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210455868.1A CN102937650B (zh) | 2012-11-14 | 2012-11-14 | 一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102937650A CN102937650A (zh) | 2013-02-20 |
CN102937650B true CN102937650B (zh) | 2014-08-20 |
Family
ID=47696561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210455868.1A Active CN102937650B (zh) | 2012-11-14 | 2012-11-14 | 一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102937650B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104345141A (zh) * | 2013-08-08 | 2015-02-11 | 北京和杰创新生物医学科技有限公司 | 检测膜条的生产方法及其模具 |
CN104459159A (zh) * | 2014-12-23 | 2015-03-25 | 广州南杰生物技术有限公司 | 一种检测自身免疫肝病相关自身抗体谱的试剂盒 |
CN107525924B (zh) * | 2017-08-28 | 2019-04-23 | 青岛瑞思德生物科技有限公司 | 一种自身免疫肝病抗体检测试剂盒 |
CN109596840A (zh) * | 2019-01-10 | 2019-04-09 | 江苏三联生物工程有限公司 | 一种用于原发性胆汁肝硬化标志物检测的蛋白芯片及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596501B2 (en) * | 1998-02-23 | 2003-07-22 | Fred Hutchinson Cancer Research Center | Method of diagnosing autoimmune disease |
US20030113758A1 (en) * | 2001-08-14 | 2003-06-19 | Pierre Oudet | Method for the in vitro diagnosis of a predisposition to bladder cancer or of the occurrence of bladder cancer and a kit for performing said diagnostic method |
CN102023216A (zh) * | 2009-09-16 | 2011-04-20 | 中华人民共和国陕西出入境检验检疫局 | 一种对乙肝、丙肝、梅毒、艾滋病原体进行共检的悬浮芯片检测方法 |
CN102323404A (zh) * | 2011-05-18 | 2012-01-18 | 高翔 | 一种自身免疫抗体检测试剂盒及检测方法 |
CN102520159A (zh) * | 2011-12-22 | 2012-06-27 | 北京海瑞祥天生物科技有限公司 | 带有临界值线的酶免疫分析膜条及其判读方法 |
CN202486138U (zh) * | 2012-03-22 | 2012-10-10 | 四川省新成生物科技有限责任公司 | 线性免疫法检测膜条 |
-
2012
- 2012-11-14 CN CN201210455868.1A patent/CN102937650B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102937650A (zh) | 2013-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102937648B (zh) | 一种检测自身免疫疾病相关抗核抗体谱的试剂盒 | |
WO2017107974A1 (zh) | 血清psmd4蛋白的检测试剂盒及其检测方法与应用 | |
Grebenschikov et al. | A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols | |
CN108088839B (zh) | 一种尿微量白蛋白/尿肌酐检测试剂盒 | |
CN102937650B (zh) | 一种检测自身免疫肝病相关自身抗体谱的试剂盒的膜条的制备方法及其构成的试剂盒 | |
CN102159591A (zh) | 单克隆抗体和使用所述单克隆抗体的免疫测定法 | |
CA2965189C (en) | A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens | |
CN105548547A (zh) | 基于流式细胞仪的检测肺癌标志物的流式阵列免疫分析试剂盒 | |
US20050019837A1 (en) | Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin | |
CN102944676B (zh) | 一种检测血管炎相关自身抗体谱的试剂盒 | |
CN104459159A (zh) | 一种检测自身免疫肝病相关自身抗体谱的试剂盒 | |
CA2464466A1 (en) | Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae | |
US20210247392A1 (en) | Direct immunoassay measurement of autoantibodies | |
Owen et al. | Performance characteristics of the IMMULITE 2000 erythropoietin assay | |
Ledue et al. | Development of immunoturbidimetric assays for fourteen human serum proteins on the Hitachi 912™ | |
CN114835808B (zh) | 可定向消除假阳性的阻断剂及其制备方法 | |
CN105891194A (zh) | 抗心磷脂抗体IgG化学发光免疫检测试剂盒及其制备方法 | |
Mattia et al. | A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay | |
Rayana et al. | Recommendation for measuring and reporting chloride by ISEs in undiluted serum, plasma or blood: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division, Committee on Point of Care Testing and Working Group on Selective Electrodes | |
CN110687285B (zh) | 诊断试剂盒及mak16在制备系统性红斑狼疮早期诊断试剂中的应用 | |
CN105445452A (zh) | 一种抗gp210抗体检测试剂盒及其检测方法 | |
CN203191382U (zh) | 一种检测多种抗核抗体的免疫印迹试剂盒 | |
Murthy et al. | Activity concentration and mass concentration (monoclonal antibody immunoenzymometric method) compared for creatine kinase MB isoenzyme in serum. | |
US8916354B2 (en) | Bladder cancer diagnosis composition containing APE1/Ref-1 and bladder cancer diagnostic kit using same | |
CN111398600A (zh) | 一种人源可溶性bcma蛋白的elisa检测试剂盒及其使用方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: High tech Zone Tianchen road Chengdu City, Sichuan province 610000 No. 88 Applicant after: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Address before: High tech Zone Tianchen road Chengdu City, Sichuan province 610000 No. 88 Applicant before: Sichuan Province Xincheng Biological Technology Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SICHUAN XINCHENG BIOTECHNOLOGY CO., LTD. TO: SICHUAN XINJIANKANGCHENG BIOLOG TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of membrane strip of kit for detecting autoantibody spectrum related to autoimmune liver disease (AILD) and kit composed of same Effective date of registration: 20161214 Granted publication date: 20140820 Pledgee: Chengdu technology transfer (Group) Co., Ltd. Pledgor: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Registration number: 2016990001096 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171222 Granted publication date: 20140820 Pledgee: Chengdu technology transfer (Group) Co., Ltd. Pledgor: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Registration number: 2016990001096 |